Noxopharm Quote - NOX

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.09

Bid

0.087

Ask

0.093

Volume

81,169

0.087 Day's Range 0.09

0.051 52 Week Range 0.15

Market Cap

26.301M

Previous Close

0.087

Open

0.09

Last Trade

2356

0.09

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

144,537

Shares Outstanding

292,237,950

Dividend Yield

PE Ratio

-7.38

Earnings Per Share (EPS)

-0.01

Revenue

2.4M

Net Profit

-3.58M

Sector

Drugs And Proprietary-whsl

Industry

Drugs And Proprietary-whsl

Website

www.noxopharm.com

Headquarters

Sydney, New South Wales, Aus

Founded

Noxopharm Limited is listed in the Drugs And Proprietary-whsl sector of the Australian Stock Exchange with ticker NOX. The last closing price for Noxopharm was AUD0.09. Over the last year, Noxopharm shares have traded in a share price range of AUD 0.051 to AUD 0.15.

Noxopharm currently has 292,237,950 shares outstanding. The market capitalization of Noxopharm is AUD25.42 million. Noxopharm has a price to earnings ratio (PE ratio) of -7.38.

FDA Grants Orphan Drug Designation to Noxopharm for Sarcoma Treatment

Australian biotech company Noxopharm (ASX:NOX) has announced the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to Veyonda®, its lead oncology drug candidate, for...

Sarcoma Trial for New Cancer Treatment Begins at City of Hope in Los Angeles

Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its Phase 1 CEP-2 sarcoma trial is underway with a first patient enrolled and dosed at City of Hope in Los...

Noxopharm In-Licenses Novel RNA Technology From Hudson Institute of Medical Research

Exclusive deal for cutting-edge RNA technology in drug discovery and vaccines Australian clinical-stage drug development company Noxopharm (ASX:NOX) has in-licensed novel RNA technology...

Noxopharm Announces DARRT-2 Clinical Trial in U.S.

Experimental Immunotherapy Cancer Treatment Enters Phase 2 Australian clinical-stage drug development company Noxopharm (ASX:NOX) has announced its DARRT-2 Phase 2 clinical trial has commenced...

ノクソファームの前臨床データがCOVID-19の治療におけるイドロノキシルの抗炎症作用をさらに裏付ける

（ビジネスワイヤ） -- オーストラリアの臨床段階医薬品開発企業であるノクソファーム（ASX:NOX）は、治験薬の抗がん剤でビヨンダの有効成分となっているイドロノキシルが、早期COVID-19の治療における抗炎症薬...

Les données précliniques de Noxopharm confirment le rôle anti-inflammatoire de l’idronoxil dans le cadre du traitement de la COVID-19

La société australienne de développement de médicaments de stade clinique, Noxopharm (ASX : NOX) a publié des données précliniques qui viennent confirmer le rôle de l’idronoxil, médicament...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.01	12.5	0.08	0.094	0.075	201717	0.08351051	DE
4	-0.01	-10	0.1	0.1	0.075	122967	0.08625203	DE
12	-0.035	-28	0.125	0.135	0.075	144537	0.10334811	DE
26	0.018	25	0.072	0.15	0.068	249935	0.10586718	DE
52	0.02	28.5714285714	0.07	0.15	0.051	205764	0.09269323	DE
156	-0.325	-78.313253012	0.415	0.495	0.033	347444	0.12964107	DE
260	-0.165	-64.7058823529	0.255	0.99	0.033	511461	0.33717781	DE

NOX - Frequently Asked Questions (FAQ)

What is the current Noxopharm share price?

The current share price of Noxopharm is AUD 0.09

How many Noxopharm shares are in issue?

Noxopharm has 292,237,950 shares in issue

What is the market cap of Noxopharm?

The market capitalisation of Noxopharm is AUD 25.42M

What is the 1 year trading range for Noxopharm share price?

Noxopharm has traded in the range of AUD 0.051 to AUD 0.15 during the past year

What is the PE ratio of Noxopharm?

The price to earnings ratio of Noxopharm is -7.38

What is the cash to sales ratio of Noxopharm?

The cash to sales ratio of Noxopharm is 10.98

What is the reporting currency for Noxopharm?

Noxopharm reports financial results in AUD

What is the latest annual turnover for Noxopharm?

The latest annual turnover of Noxopharm is AUD 2.4M

What is the latest annual profit for Noxopharm?

The latest annual profit of Noxopharm is AUD -3.58M

What is the registered address of Noxopharm?

The registered address for Noxopharm is LEVEL 20, TOWER A, THE ZENITH, SYDNEY, NEW SOUTH WALES, 2067

What is the Noxopharm website address?

The website address for Noxopharm is www.noxopharm.com

Which industry sector does Noxopharm operate in?

Noxopharm operates in the DRUGS AND PROPRIETARY-WHSL sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
PL3OPatagonia Lithium Ltd	AUD 0.025 (150.00%)	205.36k
EDEEden Innovations Ltd	AUD 0.002 (100.00%)	1.5M
5GGPentanet Limited	AUD 0.05 (66.67%)	35.91M
TG1OTechGen Metals Ltd	AUD 0.005 (66.67%)	558.03k
EUROBEuropean Lithium Limited	AUD 0.003 (50.00%)	2M
IPTOImpact Minerals Ltd	AUD 0.001 (-50.00%)	1M
ICLOIceni Gold Limited	AUD 0.01 (-28.57%)	625k
SFGSeafarms Group Limited	AUD 0.0015 (-25.00%)	75.96k
NTMNT Minerals Ltd	AUD 0.003 (-25.00%)	192.33k
RGLRiversgold Ltd	AUD 0.003 (-25.00%)	1.02M
SYASayona Mining Limited	AUD 0.023 (-6.12%)	125.27M
AZYAntipa Minerals Ltd	AUD 0.03 (7.14%)	49.99M
LRSLatin Resources Ltd	AUD 0.165 (-2.94%)	48.1M
PLSPilbara Minerals Limited	AUD 2.39 (-2.85%)	45.16M
BTRBrightstar Resources Limited	AUD 0.0205 (0.00%)	43.1M